Results 1 to 10 of about 25,058 (175)

Targeting host deoxycytidine kinase mitigates Staphylococcus aureus abscess formation [PDF]

open access: yeseLife, 2023
Host-directed therapy (HDT) is an emerging approach to overcome antimicrobial resistance in pathogenic microorganisms. Specifically, HDT targets host-encoded factors required for pathogen replication and survival without interfering with microbial growth
Volker Winstel   +3 more
doaj   +9 more sources

Molecular Imaging of Deoxycytidine Kinase Activity Using Deoxycytidine-Enhanced CEST MRI. [PDF]

open access: yesCancer Res, 2019
Abstract Deoxycytidine kinase (DCK) is a key enzyme for the activation of a broad spectrum of nucleoside-based chemotherapy drugs (e.g., gemcitabine); low DCK activity is one of the most important causes of cancer drug-resistance.
Han Z   +6 more
europepmc   +4 more sources

Deoxycytidine kinase augments ATM-Mediated DNA repair and contributes to radiation resistance. [PDF]

open access: yesPLoS ONE, 2014
Efficient and adequate generation of deoxyribonucleotides is critical to successful DNA repair. We show that ataxia telangiectasia mutated (ATM) integrates the DNA damage response with DNA metabolism by regulating the salvage of deoxyribonucleosides ...
Yuri L Bunimovich   +7 more
doaj   +2 more sources

Danggui Buxue Decoction Sensitizes the Response of Non-Small-Cell Lung Cancer to Gemcitabine via Regulating Deoxycytidine Kinase and P-glycoprotein [PDF]

open access: yesMolecules, 2019
This study aimed to investigate whether the anti-tumor effect of gemcitabine (GEM) in non-small-cell lung cancer (NSCLC) treatment was affected by Danggui Buxue decoction (DBD), and explore the potential mechanisms. The combined use of GEM and DBD showed
Xiyang Sun   +8 more
doaj   +2 more sources

Clofarabine exerts antileukemic activity against cytarabine‐resistant B‐cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression [PDF]

open access: yesCancer Medicine, 2018
Cytosine arabinoside (Ara‐C) is one of the key drugs for the treatment of acute myeloid leukemia. It is also used for consolidation therapy of acute lymphoblastic leukemia (ALL).
Meixian Huang   +16 more
doaj   +2 more sources

Potential deoxycytidine kinase inhibitory activity of amaryllidaceae alkaloids: An in silico approach

open access: yesJournal of Pharmacy and Bioallied Sciences, 2018
Background: Plants of the Amaryllidaceae family have been under intense scrutiny for the presence of a couple of alkaloidal secondary metabolites with endued cytotoxic activity, such as pancratistatin (1), 7-deoxypancratistatin (2), narciclasine (3), 7 ...
Bashir A Yousef   +4 more
doaj   +2 more sources

Noninvasive in vivo deoxycytidine kinase (dCK)-PET identifies tumor-draining lymph nodes upon immune checkpoint inhibitor therapy [PDF]

open access: yesnpj Imaging
Efficient application of immunotherapy necessitates advanced whole-body imaging techniques to monitor sites of immune cell activation. Deoxycytidine kinase (dCK), a key enzyme in the deoxynucleotide salvage pathway, is upregulated in proliferating immune
Cécile Philippe   +16 more
doaj   +2 more sources

Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer [PDF]

open access: yesCell Death and Disease
Pancreatic ductal adenocarcinoma (PDAC) is considered one of the most lethal forms of cancer. Although in the last decade, an increase in 5-year patient survival has been observed, the mortality rate remains high.
Suman Dash   +5 more
doaj   +2 more sources

Targeted Delivery of Deoxycytidine Kinase to Her2-Positive Cells Enhances the Efficacy of the Nucleoside Analog Fludarabine. [PDF]

open access: yesPLoS ONE, 2016
Cytotoxic drugs, such as nucleoside analogs and toxins, commonly suffer from off-target effects. One approach to mitigate this problem is to deliver the cytotoxic drug selectively to the intended site. While for toxins this can be achieved by conjugating
Sujatha P Koduvayur   +3 more
doaj   +2 more sources

Potent Sensitisation of Cancer Cells to Anticancer Drugs by a Quadruple Mutant of the Human Deoxycytidine Kinase. [PDF]

open access: yesPLoS ONE, 2015
Identifying enzymes that, once introduced in cancer cells, lead to an increased efficiency of treatment constitutes an important goal for biomedical applications.
Safiatou T Coulibaly   +7 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy